纤维肌痛综合征诊治进展

The overview of diagnosis and treatment of fibromyalgia syndrome

纤维肌痛综合征,也称纤维肌痛症,是较为常见的风湿性疾病,好发于40岁以上女性人群,以全身弥漫性疼痛为主要特征,常伴有疲劳、睡眠障碍、情绪紊乱和认知功能障碍等多种非特异性临床症状,严重影响着患者的身心健康。在我国,纤维肌痛综合征"鲜为人知",在医疗界和人民大众中得不到足够的认识,患者在多个科室之间辗转求治,往往导致正确诊断和治疗的延迟,加大了患者的精神和经济负担。本文对本病的历版诊断/分类标准和最新治疗管理方法及其推荐意见予以介绍和解读,以期促进我国纤维肌痛综合征诊治水平的提高。

Fibromyalgia syndrome, also known as fibromyalgia, is a very common rheumatic disease, which mainly occurs in women over 40 years. As the main characteristic, the diffuse pain across the whole body often accompanied by fatigue, sleep disorders, mood disorders and cognitie impairment, and other nonspecific clinical symptoms, seriously affecting the patients' physical and mental health. In China, fibromyalgia syndrome is a “little known” disease and is generally not well understood by the medical community and the general public. In order to improve the level of diagnosis and management of fibromyalgia syndrome in China, this article introduces the American College of Rheumatology Research Criteria of fibromyalgia syndrome and the latest management methods.